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Obesity or maternal overnutrition during pregnancy and lactation might have long-term consequences in offspring health. Fetal
programming is characterized by adaptive responses to specific environmental conditions during early life stages. Programming
alters gene expression through epigenetic modifications leading to a transgenerational effect of behavioral phenotypes in the
offspring. Maternal intake of hypercaloric diets during fetal development programs aberrant behaviors resembling addiction in
offspring. Programming by hypercaloric surplus sets a gene expression pattern modulating axonal pruning, synaptic signaling, and
synaptic plasticity in selective regions of the reward system. Likewise, fetal programming can promote an inflammatory phenotype
in peripheral and central sites through different cell types such as microglia and T and B cells, which contribute to disrupted energy
sensing and behavioral pathways. The molecular mechanism that regulates the central and peripheral immune cross-talk during
fetal programming and its relevance on offspring’s addictive behavior susceptibility is still unclear. Here, we review themost relevant
scientific reports about the impact of hypercaloric nutritional fetal programming on central and peripheral inflammation and its
effects on addictive behavior of the offspring.
1. Introduction
According to the World Health Organization, nearly 39% of
adults aged 18 years and over were overweight in 2016, and
13% were obese. Maternal obesity adversely impacts both
maternal and offspring health, increasing the susceptibility
to show metabolic abnormalities later in life such as obesity,
dyslipidemia, type 2 diabetes mellitus, and hypertension
as well as behavioral disorders related to schizophrenia,
autism, and compulsive eating disorders [1, 2]. Maternal
obesity or maternal overnutrition programs metabolic and
hormonal nodes thatmodulate neuronal development during
embryogenesis. For instance, neuronal maturation, includ-
ing axonal pruning, synaptic plasticity, and stable tract
formation between structures, is selectively programmed
during pregnancy and lactation by consumption of high-
sugar, high-fat, or high-sugar-high-fat diet formulas. Under
this scenario, nutritional programming defines after-weaning
selective behavioral phenotypes in offspring that might be
exacerbated during adulthood, such as incentive-motivation
behaviors leading to compulsive eating disorders.
Maternal obesity or overnutrition during fetal program-
ming activates molecular and cellular mechanisms that com-
mand a new physiological state that might compromise basic
metabolic and neuronal homeostasis. Metabolic imbalance
during obesity can lead to overactivation of the immune
system, triggering a process of chronic inflammation evi-
denced in animal models and humans. In fact, nutritional
programming by hypercaloric diets promotes an inflamma-
tory phenotype that contributes to disrupted energy sensing
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pathways in metabolic-relevant systems including adipose
tissue, liver, pancreas, muscle, and the brain. Inflammation in
the brain is associated with a cross-talk between peripheral
and central cell types that potentially activates microglia in
the brain. However, it is still unclear which immune cells
infiltrate into the fetal brain leading to microglia activation
and neuroinflammation during maternal nutritional pro-
gramming.Moreover, it is unknown ifmaternal overnutrition
during fetal programming originates central inflammation by
microglial activation in the absence of peripheral immune
cells infiltration. Finally, the role of neuroinflammation
during maternal nutritional programming and its effects on
defective behavior related to compulsive eating disorders
in the offspring have only started to be dissected. In this
review, we will discuss the role of maternal programming on
peripheral and central immune cross-talk and its relevance
in the development of incentive-motivation behavior such as
addiction in the offspring.
Obesity is a metabolic condition showing positive energy
balance driven by several factors including human genetics,
life style, environment, body activity, and diet [6]. At first,
obesity was conceived as a metabolic disorder showing an
increase in white adipose tissue mass-modulated exclusively
by the peripheral nervous system. However, recent evidence
shows that the central nervous system (CNS) plays a major
role in the modulation of adipose tissue mass and func-
tion. Also, the CNS is a major regulator of food intake
and metabolism and seeks for rewards such as food; in a
pathological state, CNS activation might lead to addiction-
like behavior [7].
2. Obesity Is a Potential Deregulator of
Energy-Satiety Integration in the CNS,
Leading to Overfeeding
In nature, all living organisms require energy to sustain
life and perform activities. Energy is mainly provided by
food assigned into three main formulas such as proteins,
carbohydrates, and fats. However, energy surplus such as
overnutrition disrupts metabolic and hormonal homeostasis
and has harmful consequences in health. On this matter,
metabolic and hormonal signals from the periphery arrive to
the CNS to give a message about the energy balance of the
body.TheCNS integrates these signals through evolutionary-
conserved neuronal tracts connecting peripheral organs to
selective brain structures. For instance, the brainstem receives
information from the gut, while the hypothalamus integrates
circulating/humoral signals. The brainstem and hypothala-
mus control satiety and integrate these signals by sayingwhen
and how much to eat [7]. However, under a pathological
scenario satiety might be overestimated, leading to activa-
tion of the reward system, which modulates the incentive
motivation to work and search for food despite an “apparent”
satiety signal. The reward system integrates dopaminergic
neurons located in the ventral tegmental area (VTA) that
project to the nucleus accumbens (NAc) and also innervate
several regions of the prefrontal cortex (PFC), central amyg-
dala, basolateral amygdala (BLA), and hippocampus and
dopamine neurons in the substantia nigra (SN) that project
to the dorsal striatum,which has traditionally been associated
with appetitive learning, performance, and motivation [8]. It
has been hypothesized that incentivemotivation for palatable
food contributes to overfeeding during obesity [9, 10]. For
instance, an evasion of satiety has been identified in obesity
leading to positive energy balance and an increase of body
mass index [11, 12]. Several researchers propose that, like
drug-addiction, obesity sets an altered motivational behavior
for seeking foods rich in fat and sugars (hypercaloric) that
have high reward value (pleasant), which is potentially
dependent on dopamine neurotransmission [10].
The proposal that overeating during obesity might be
considered as food addiction in the Diagnostic and Statistical
Manual of Mental Disorders (DSM) was initially based on
phenotypic similarities between patterns of overeating in
obese individuals and drug abuse in addicted persons. It
has been shown in both animal models and humans that
repeated exposure to high-fat or high-sugar diets disrupts
the integration of energy-satiety peripheral signals into the
CNS, leading to overfeeding which indeed shares behavioral
similarities to addiction [10, 13]. For instance, obese humans
might experience the following: (1) enhancedmotivation over
hypercaloric food intake including recurrent and excessive
consumption, (2) an increased time spent seeking palatable
food in contrast to habitual activities, and (3) frequent or per-
manent relapse to hypercaloric foods after dieting. Of note,
obesity or palatable food overconsumption might be subject-
specific and it is potentially modulated by environment-
subject interaction. Based on this proposal, researchers have
applied a selective Yale Food Addiction Scale (YFAS) to pro-
vide a standardizedmeasure for the assessment and diagnosis
of food addiction based mainly on substance dependence
criteria [14, 15]. These evidences suggest that overfeeding
during obesity might be related to incentive motivation for
palatable food in human and animals. However, are humans
born addicted or do they become addicted to food?
3. Potential Role of Fetal Programming by
Hypercaloric Food in the Development of
Addictive Behaviors in the Offspring
Exposure to hypercaloric foods impacts the individual
metabolic-hormonal settings of mothers and fathers and
might also affect their offspring. Substantial scientific evi-
dence has demonstrated the detrimental role of hypercaloric
food intake during pregnancy and lactation leading to a
failure in metabolic homeostasis, favoring the development
of incentive-motivation behavior for food in the offspring. In
this context, epidemiological data from human catastrophes
such as the Dutch famine (1944), the siege of Leningrad
(1942–1944), the great Chinese famine (1958–1961), and also
the O¨verkalix study (1890-present) have shown that changes
in diet intake regarding overfeeding or fasting are associated
with disorders in the offspring such as diabetes mellitus type
2 and cardiovascular diseases [16–19]. In addition, there is
evidence of behavioral alterations, including schizophrenia
[20–22], affective disorders [23], and addiction [24, 25]. Based
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on this data, Barker (1998) proposed the “Barker hypothesis”
suggesting that the transgenerational effect of diet expo-
sure during pregnancy modulates metabolic and behavioral
phenotypes in the offspring, a mechanism known as “fetal
programming” [26]. In specific, this hypothesis claims that
oversupply or absence of energy intake during embryonic-
fetal development provides the fetus with physiological adap-
tations to a new milieu of metabolic-hormonal threshold
to face a potential adverse postnatal environment similar to
those whose parents were exposed to fetal programming.
In fact, any stimulus or insult throughout embryonic-fetal
development, including stress, infections, substance abuse,
overnutrition, and behavioral alterations, might result in
molecular adaptations that produce permanent structural,
physiological, and metabolic changes in the fetus. Also, fetal
programmingmight increase the risk of serious physiological
problems in perinatal stages including miscarriage, fetal-
congenital anomalies, thromboembolism, and gestational
diabetes.
Initial reports demonstrated that energy-dense food dis-
rupts the appetite-energy sensing and satiety systems, exac-
erbating the reward for food. Also, excessive consumption
of palatable food can lead to a profound hyposensitivity
to reward, leading to compulsive eating behavior similarly
observed during drug seeking [27]. Nutritional program-
ming in murine models induces alterations in behavior and
synaptic plasticity, favoring higher consumption and sensiti-
zation to alcohol, methamphetamines, and cocaine [28, 29].
Maternal exposure to hypercaloric diets during pregnancy or
lactation has shown to increase the long-term preference for
junk food in the offspring [30], potentially associated with
repeated, intermittent increases in extracellular dopamine
(DA) in the NAc and the VTA [31–35]. Molecularly, these
synaptic plasticity changes show greater expression of the
ΔFosB gene [28] and both dopamine (e.g., DR2, DAT)
and opioid pathway genes expression (e.g., the 𝜇-opioid
receptor) at early stages of development [35–39]. In fact, the
opioid pathway regulates the rewarding effects of palatable
food; an injection of 𝜇-opioid agonists in the NAc increases
preference for high-fat or sugar-rich foods [40, 41], and
its antagonists decrease palatable food predilection, even at
doses that show no effect on standard food intake [42, 43].
In addition, fetal programming by drugs such as nicotine
exposure during pregnancy might also disrupt brain gene
expression involved in neuronal glutamatergic (e.g., GluA1,
GluA2, and CaMKII𝛼) and dopaminergic (e.g., DR2, DAT,
and DR1) signaling plasticity in the hippocampus [44, 45],
the laterodorsal tegmental nucleus [46], and theNAc [47–49].
In murine maternal overnutrition models, a transcription
modulation of glutamatergic and dopaminergic systems in
the NAc and prefrontal cortex that increases fat/sugar food
preferences in the offspring has been identified [50–53]
(Figure 1).
In humans, it is still under investigation if obesity or
maternal overnutrition during pregnancy leads to the devel-
opment of food addiction in the offspring. Initial reports
found that children from obese mothers or mothers with
eating disorders presentedmore binge eating and night eating
[54, 55] and consumedmore carbohydrates compared to their
normal weight counterparts [56]. Also, a positive correla-
tion between addicted parents and food addiction in their
offspring has been proven [57], although epidemiological
studies are needed to support these findings.
4. Obesity and Maternal
Overfeeding Promote Peripheral and
Central Inflammatory Response
An organism’s first line of defense is the innate immune
system and it includes physical barriers such as the skin,
specific cell types such as macrophages, and complement
proteins. The second line of defense is the inflammatory
response which consists of an innate cellular system and
humoral response that happens during injury to restore phys-
iological homeostasis. The function of the immune system is
not limited to fighting infections and repairing tissue damage,
it also plays a key role in shaping neuronal tracts during CNS
development. For instance, cells from the innate immune
system, such as microglia, regulate neurogenesis, synaptic
plasticity, and synaptic striping, and are the major antigen-
presenting cells (APC) in the CNS [58]. Cross-talk between
peripheral immune system and brain-resident immune cells
is in part regulated by B and T lymphocytes, macrophages,
and antibodies which migrate and penetrate the blood-brain
barrier (BBB) [58, 59] and have also been reported in the
cerebrospinal fluid [60]. Under an altered physiological sce-
nario, peripheral immune cells located in the brain become
proinflammatory entities and secrete cytokines promoting
an exacerbated immune response by microglia. By doing
this, peripheral immune cells integrate positive feedback with
microglia that modulates neural growth and development
[61]. Microglial cells are the brain-resident macrophages of
the CNS; these oversee surveillance of the CNS integrity and
respond to pathogens and injuries and also to very subtle
alterations in their microenvironment [62]. In healthy brains,
microglia remain in a ramified stated, and when activated,
they enlarge their cell body, change to a phagocytic state,
and execute similar functions to those of other tissue-resident
macrophages such as proinflammatory cytokines secretion,
antigen presentation, and ROS production and phagocytosis,
leading to neuroinflammation [63]. Under this scenario,
neuroinflammation is beneficial because it removes debris or
dysfunctional neurons; under a pathological state, however,
microglia activation is upregulated and can be damaging
to neurons because of the excessive release of ROS and
proinflammatory cytokines, leading to neuroinflammation
[64], and might contribute to tissue damage and disease
pathology. Although microglial activation could be harmful,
microglia are necessary to provide essential trophic factors
for the survival of neurons, like brain-derived neurotrophic
factor (BDNF) and glial-derived neurotrophic factor (GDNF)
[63].
An atypical form of inflammation, primarily induced
by fatty acids accumulation in selective energy-dependent
tissues including liver, adipose tissue, muscle, and brain
occurs when there is a positive energy balance, as found in
obesity or maternal overnutrition, [65]. Fatty acids promote
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Figure 1: Maternal programming by hypercaloric diets increases the development of addictive behavior in offspring. (a) Hypercaloric diet
intake or obesity during pregnancy leads to activation of an inflammatory state of mothers (F0), favoring aversive intrauterine environment
and selective increase in proinflammatorymarkers. (b) Positive inflammatory state inmothers correlates with the one in the offspring (F1) and
also with activation of fetal epigenetic program including DNAmethylation, histone modification (ip acetylation, methylation, sumoylation,
and ubiquitination), and noncoding RNAs (ipmiRNA, piRNA, and lncRNA), which are capable of altering gene expression profile in selective
regions belonging to the reward system: prefrontal cortex (PFC), nucleus accumbens (NAc), and ventral tegmental area (VTA). (c) Epigenetic
programming associates with neurodevelopment alterations in F1 including synaptic signaling, synaptic plasticity, and neurogenesis which
contributes to addictive-like behavior.
a type of body inflammation termed “metainflammation” or
“metabolic inflammation,” which involves several immune
cells (T, B lymphocytes and microglia) and proinflammatory
mediators (cytokines and chemokines) leading to metabolic
and neurodegenerative disorders [66, 67]. Obesity or over-
nutrition during pregnancy leads to maternal immune acti-
vation (MIA), which favors changes in plasma and placen-
tal tissue-specific lipidomic profile, recruiting lipid species
to membrane Toll-Like Receptor 4 (TLR4) and activating
the nuclear factor-kappa B (NF-𝜅B) pathway, through an
increase of TLR2, TLR4, IL-6, IL-18, and TNF-𝛼 mRNA
levels and macrophage markers cluster of differentiation
including (CD)11b, CD14, and CD68 [68–70]. Maternal
overnutrition in a sheep model of obesity demonstrated that
inflammatory markers such as CD-68, TGF-𝛽1, and TNF-
𝛼 found in the mother are also identified in the offspring
after birth [71]. These evidences show that imbalances in the
peripheral and immune system cross-talk might compromise
early stages of CNS development and differentiation poten-
tially contributes to epilepsy, schizophrenia, cerebral palsy,
Parkinson disease (PD), Alzheimer disease (AD), and ASD
[72].
5. Central-Peripheral Immune System
Cross-Talk Regulates Synaptic Plasticity,
Neurogenesis, and Neurodegeneration
As mentioned before, neuroinflammation is how the innate
immune system protects the CNS and controls initial stimu-
lus, and although it is intended to be protective and beneficial,
out-of-control inflammation can be fatal and contribute to
tissue damage and disease pathology, including neurodegen-
eration [73]. Substantial scientific evidence has shown that
neuroinflammation commands changes in cerebral plasticity
and influences synaptic function andmemory [72]. However,
there are no conclusive data showing a cause-effect relation-
ship in terms of the role of cytokines on synaptic plasticity
modulation in the NAc, as a trigger to addictive behavior.
Some data from neuroimmune interactions in humans in the
behavioral response to drugs have shown small clues about
their clinical relevance; however, these studies do not identify
the molecular mechanisms of such interactions [74, 75].
Cause-effect relationship is even harder to identify because
the CNS shows a selective cytokine profile when compared
to peripheral cytokines during drug exposure. For instance,
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Figure 2: Synaptic modulation by cytokine levels. (a) According to Bettie and cols. in 2002 and Stellwagen and cols. in 2006 results TNF-𝛼
was demonstrated to promote normal expression of AMPARs favoring synaptic strength at excitatory synapses. (b) In contrast, high levels of
TNF-𝛼 can affect synaptic plasticity by removing of Ca2+-permeable AMPARs from plasma membrane according to Lewitus et al., 2014 (b).
(c) Physiological levels of IL-1𝛽 and IL-6 are detrimental to maintain and modulate hippocampus activity [3, 4]. (d) Excess of IL-1𝛽 and IL-6
affect LTP and impair memory formation [3, 5].
Calipari and colleagues did not find differences between the
TNF-𝛼 expression in serum when mice were exposed to
cocaine [76]. However, Lewitus et al. identified TNF-𝛼 release
from microglia after cocaine consumption as a potential
regulation of neuronal and behavioral plasticity during both
the induction and expression of drug-induced behaviors [77].
Molecularly, initial reports have shown that glia releases
TNF-𝛼 to fit surface expression of AMPARs, favoring the
synaptic strength at excitatory synapses [78, 79]. In fact, TNF-
𝛼 stimulation in brain slices reduced corticostriatal synaptic
strength by removing of Ca2+ permeable AMPARs from
the plasma membrane [80], suggesting that high levels of
TNF-𝛼 affect synaptic plasticity, but physiological levels favor
brain development and synaptic strength [79] (Figure 2).
These evidences reinforce the previous hypothesis that TNF-
𝛼 profile in the CNS modulates synaptic plasticity during
addiction; however, it is still unknown whether central TNF-
𝛼 accumulation might be a node of inflammatory activation
during addiction or there is a cause-effect relationship involv-
ing a cross-talk between peripheral and central mechanism.
Synaptic plasticity during addiction might also be mod-
ulated by chemokines. For instance, the CCL4 and CCL17
chemokines and their ligand CCL25 are upregulated in
microglia following morphine treatment and might also
6 BioMed Research International
induce local chemotaxis of axon terminals or dendritic
spines. Blocking the synthesis of certain chemokines pre-
vents the relapse of drug-seeking behavior following drug
reexposure months later [81]. In addition, the modulation
of the G-CSF chemokine concentration in the NAc and the
prefrontal cortex is crucial to alter the motivation of cocaine
consumption but not of food [76]. Together, chemokines have
a very profound neuromodulatory effect on the regulation
of neural circuits involved in addiction, but the molecular
mechanisms on this scenario still need to be described in
detail.
Central and peripheral immune cross-talk response
might also modulate hippocampal neurogenesis. It has been
reported that when CD4+ T lymphocytes are systemically
depleted in mice, there are reduced hippocampal neuroge-
nesis, learning impairment, and a decrease in BDNF secre-
tion in the brain, whereas inoculation of CD4+ T lympho-
cytes promotes hippocampal neurogenesis and restores the
deficits observed before [82, 83]. In models of autoimmune
encephalitis in which inflammatory responses are upreg-
ulated, synaptic plasticity in the hippocampus and long-
term potentiation (LTP) are affected because of the high
levels of IL-1𝛽. While peripheral inflammatory responses
related to TNF-𝛼 and IL-6 have been identified to modulate
hippocampus activity [84, 85], it has not been fully described
whether central IL-1𝛽 comes from infiltrating lymphocytes or
activated microglia within the CNS [86]. In any case, central
physiological levels of IL-1𝛽 are detrimental, because exces-
sive cytokines level or blockage of IL- 1 signaling through
IL-1ra has been reported to cause memory impairment [87],
potentially due to Ca2+ influx throughout NMDA receptors,
Src kinases activation, and NR2A/B subunits phosphoryla-
tion [88].
As mentioned before for TNF-𝛼 and IL-1𝛽, initial reports
characterized that the IL-6 cytokine is required in normal
physiological levels for the formation of LTP, but levels
above normal affectmemory formation and learning [89, 90].
Supporting those findings, IL-6 KO mice display memory
impairment [84] and show reduced proliferating neuronal
stem cells (NSCs) in the hippocampus [91]. Under physi-
ological conditions, IL-6 is related to neural plasticity and
NSCs proliferation through the JAK/STAT, MAPK/cAMP,
Ras-MAPK, and PI3K pathways [92]. Lastly, the immune
system is involved in regulation of hippocampal neurogene-
sis, through the kynurenine pathway [93], affecting directly
the hippocampal neurogenesis and memory and learning
processes [82] (Figure 2).
A positive inflammatory profile including the IL-1, IL-6,
IL-1𝛽, TNF-𝛼, and IFN-𝛾 has been evidenced in a wide range
of neurodegenerative diseases. In particular, TNF-𝛼 produc-
tion by active microglia is highly related to IFN-𝛾 secreted
by T cells into the CNS parenchyma [3]. Secreted IFN-𝛾 and
other inflammation mediators activate the MEK/ERK sig-
naling pathway leading to TNF-𝛼 production and neuronal
death [4]. Also, TNF-𝛼 and IFN-𝛾 lead to microglial nitric
oxide (NO) production, favoring oxidative stress, inhibiting
neuronal respiration, and favoring neuronal apoptosis [94].
Of note, these responses seem to be independent, although
there might be a node at different time-frame. For instance,
the TNF-𝛼 targets its own receptor to activate the NF-𝜅B-
dependent proinflammatory pathway and the expression of
inducible NO synthase (iNOS) thatmediates NOproduction,
which is regulated by NF-𝜅B and STAT transcription factors
[95].
In addition, IL-6 also might potentially favor neuronal
death. By promoting the formation of the IL-6/IL-6R/gp130
complex, the proinflammatory IL-6 activates the JAK1, JAK2,
and TYK2 pathway and promotes the phosphorylation of
STAT1 and STAT3. In specific, IL-6 favors neuronal death
by the STAT1 nuclear transcription factor, which associates
with transcription of IFNs, including type I (IFN-𝛼, IFN-
𝛽, and IFN-𝜔) and type II (IFN-𝛾), all of them involved
in detrimental innate immune responses. However, IL-6
might also be anti-inflammatory and promote cell survival
through STAT3-PI3K/Akt signaling activation by regulating
cell cycle proteins (CDK2), antiapoptotic proteins (Bcl-2),
and proapoptotic proteins (Bax, Bad, and caspase-9) [5,
96]. Thus, IL-6 secretion by activated microglia regulates
inflammatory mediators and shows a dual role that prevents
or promotes neuronal death.
In summary, because of their dual roles associated with
threshold levels, cytokines in the brain may help to maintain
cerebral homeostasis having a beneficial effect in normal
physiological conditions; uncontrolled or chronic neuroin-
flammation, however, leads to neurodegeneration, disruption
of cerebral plasticity, cognitive changes, and the appearance
of aberrant behavior, also defined as “sickness behavior” by
Cibelli and colleagues [74].
6. Epigenetic Mechanisms during Fetal
Programming and Transgenerational
Inheritance of Addictive Phenotype
By now, we have shown evidences that metabolic inflam-
mation during pregnancy leads to chronic inflammation in
offspring that might disrupt synaptic plasticity and set a
self-perpetuating cycle of addictive excessive consumption
of natural and synthetic rewards [28, 97]. Despite the lack
of epidemiological studies addressing the impact of human
obesity or maternal overnutrition as a node to promote
addiction-like phenotypes in offspring, recent evidence sug-
gests that addiction in humans might have a common root
from transgenerational inheritance, given that biomarkers
that share identity in drug programming and addictive
behavior have been previously described [98–101]. A trans-
generational inheritance of addiction, eating disorders, or
pathological phenotypes in offspring is modulated directly
by epigenetics, which programs and adapts organisms in
the early stages of development to face sudden changes in
the environment, compared with evolutionary and natural
selection processes, which tend to be slow [102]. Epigenetics
refer to the mechanisms of long-term or stable regulation
of gene expression that do not involve a change in gene
sequences including DNA methylation and histone mod-
ification such as acetylation, sumoylation, ubiquitination,
and methylation, as well as gene expression regulated by
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noncoding RNAs, miRNAs, piRNAs, and lncRNA [103].
The role of maternal programing by overnutrition during
pregnancy and its effects on epigenetics linked to a proin-
flammatory profile in offspring have not been deeply analyzed
yet. Initial work has shown that epigenetics modulate the
immune system and potentially affects the CNS during
pregnancy [103]. A recent paper identified that fat diet primes
an epigenomic reprogramming of myeloid progenitor cells
that led to an increased proliferation and enhanced innate
immune responses [104], which the authors named as “innate
immune memory” or “trained immunity,” able to mediate
metabolic reprogramming for prolonged periods of time
[105]. On this context, using a fetal-programing murine
model with hypercaloric diet, Edlow et al. (2016) identified
a significant number of deregulated miRNAs implicated
in immune and proinflammatory processes, death cellular,
adipogenesis and cellular stress in the males of offspring
[106] (Figure 1). In humans, a positive correlation between
body mass index (BMI) during prepregnancy with adiposity
and inflammatory markers in offspring at birth has been
demonstrated [107]. Also, Alexander and col. (2018) reported
alterations in the methylation profile of genes involved in
mitochondrial function, DNA repair, oxidative stress and
inflammation in the placenta of childrenwhowere born from
mothers with type 2 diabetes mellitus [108]. Of importance,
a study in humans revealed that an adherence to Mediter-
ranean diet for 5 years ended up in a significant increase in
DNA methylation which positively correlated with a reduc-
tion in the concentrations of TNF-𝛼, sICAM-1, and CRP
[109].
These evidences suggest that gestational exposure to
high-fat and high-sugar diets in murine models results in
a disruption of the central reward system, which correlates
with epigenetic biomarkers found in addicted-programed
subjects. Programming sets the brain to potentiate changes
in neuroplasticity [97, 110], neuronal death, neurotoxicity
[111], etc., in postnatal life, which leads to the development of
cognitive disorders such as addiction [112–115]. It is still under
investigation if humans share the aberrant reward plasticity
that has been described in murine models.
7. Conclusions
Maternal overnutrition leads to fetal adaptive responses
which sets a neuronal gene expression program in offspring.
Selective intake of diets rich in fats and sugars at critical
stages recruit central and peripheral inflammatory cell type
markers, such as microglia and T and B cells, which disrupt
energy sensing and behavioral pathways increasing the sus-
ceptibility to show aberrant behaviors similar to addiction.
In fact, an addictive phenotype might be transgenerational
when inherited by selective epigenetic activation during fetal
programming. These evidences propose the immune system
activation by nutritional programming during gestation as
a node to modulate changes in neuroplasticity related to
incentive behavior phenotypes which must be addressed
deeply for a better understanding.
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